Selected Press Releases
and Publications
Shmuel Einav, Ph.D. Wins 2012 Landau Prize for Scientific Research
Announcement, February 12, 2013
Walter Flamenbaum, M.D. joins The Channel Group, LLC as Managing Partner
Announcement, December 12, 2012
Biomedical Conference in Israel Held in Honor of Shmuel Einav, Ph.D.
Announcement, March 12, 2012
An Interview with Vijay Aggarwal, Ph.D.
Newsletter, September 26, 2011
Shmuel Einav, Ph.D. Joins The Channel Group, LLC as an Advisory Partner
Press Release, May 17, 2011
Vijay Aggarwal, Ph.D. Appointed to the Board of Directors of HYCOR Biomedical, Inc.
Press Release, May 16, 2011
SuperGen and Astex Therapeutics Enter Definitive Merger Agreement
Allan Goldberg serves as a member of SuperGen's Board of Directors and
Chairman of its Scientific Advisory Board.
Press Release, April 6, 2011
BioMarin Pharmaceutical Acquires ZyStor Therapeutics
Allan Goldberg is a co-founder of ZyStor Therapeutics and a co-inventor of its core technology, additionally he served on ZyStor's Board of Directors.
Press Release, August 17, 2010
Phage Pharmaceuticals Launched — Receives Funding for Purchase of Assets
Partners of The Channel Group appointed to Board of Directors and Management of Phage Pharmaceuticals.
Press Release, May 24, 2010
Vijay Aggarwal, Ph.D. Joins The Channel Group, LLC as a Partner
Press Release, December 3, 2009
Lesanne Life Sciences Named Life Sciences Company of the Year by the Connecticut Technology Council
Press Release, September 17, 2008
The Channel Group partners with Pacific Channel Limited and New Zealand Venture Investment Fund to invest NZ$8-12 million into new biotech ventures
Press Release, June 5, 2008
"Securing Greater Returns Through Life Sciences Investments"
Presentations by Robert Beckman and Allan Goldberg, Ph.D. at an Ernst & Young
Seminar in Auckland, New Zealand.
Meeting Announcement, April 14, 2008
E-Z-EM to Merge with Bracco Diagnostics in $241 Million Transaction
Robert Beckman served on the Executive Committee of E-Z-EM, Inc.
Press Release, October 30, 2007
Living Cell Technologies Enhances U.S. Capabilities: Appoints The Channel Group to Lead Commercial and Capital Markets Initiatives
Press Release, July 2, 2007
Blood test for stroke under development by The Channel Group's recently formed company, Lesanne Life Sciences
Press Release, May 29, 2007
Lesanne Life Sciences presents poster and gives presentation at the BIO 2007 Innovation Corridor
Presentation Poster, April 26, 2007
"No Middle Ground"
Philip Sussman established multiple pharmaceutical strategic alliances.
BioCentury, March 22, 2004
"Pharmacogenomics Checklist"
Article by Philip Sussman based on his presentation at the Technology Development Workshop in Pharmacogenomics at the Drug Discovery Technology Conference.
Current Drug Discovery, February 2004